SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001078782-16-002945
Filing Date
2016-06-06
Accepted
2016-06-06 16:20:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G f13g060616_sc13g.htm SC 13G 52580
  Complete submission text file 0001078782-16-002945.txt   54108
Mailing Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Business Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212 (424) 230-7001
Rich Pharmaceuticals, Inc. (Subject) CIK: 0001504389 (see all company filings)

IRS No.: 463259117 | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-86921 | Film No.: 161698767
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1218 UNION STREET, SUITE 2 BROOKLYN NY 11225
Business Address 1218 UNION STREET, SUITE 2 BROOKLYN NY 11225 212-444-9858
LG CAPITAL FUNDING, LLC (Filed by) CIK: 0001585346 (see all company filings)

IRS No.: 461906523 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G